Source:http://linkedlifedata.com/resource/pubmed/id/16291592
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2006-2-22
|
pubmed:abstractText |
Patients with t(8;21) acute myeloid leukemia (AML) are considered to have a good prognosis; however, approximately 50% of them relapse. The genetic alterations associated with a poor outcome in t(8;21) AML remain unknown. Recently, aberrations of receptor tyrosine kinases (RTKs) were frequently found in patients with AML. However, the prevalence and prognostic impact of RTK aberrations in pediatric t(8;21) AML remains undetermined. Here, we found the kinase domain mutations of the KIT gene in 8 (17.4%) of 46 patients with t(8;21) AML among newly diagnosed pediatric patients with AML treated on the AML99 protocol in Japan. Significant differences between patients with or without KIT mutations were observed in the 4-year overall survival (50.0% versus 97.4%, P = .001), disease-free survival (37.5% versus 94.7%, P < .001) and relapse rate (47.0% versus 2.7%, P < .001). Furthermore, FLT3 internal tandem duplication was found in only 2 (4.3%) patients. These results suggested that KIT mutations are strongly associated with a poor prognosis in pediatric t(8;21) AML.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0006-4971
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
107
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1806-9
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:16291592-Adolescent,
pubmed-meshheading:16291592-Child,
pubmed-meshheading:16291592-Chromosomes, Human, Pair 21,
pubmed-meshheading:16291592-Chromosomes, Human, Pair 8,
pubmed-meshheading:16291592-DNA Mutational Analysis,
pubmed-meshheading:16291592-Disease-Free Survival,
pubmed-meshheading:16291592-Female,
pubmed-meshheading:16291592-Gene Duplication,
pubmed-meshheading:16291592-Humans,
pubmed-meshheading:16291592-Infant,
pubmed-meshheading:16291592-Leukemia, Myeloid, Acute,
pubmed-meshheading:16291592-Male,
pubmed-meshheading:16291592-Prevalence,
pubmed-meshheading:16291592-Prognosis,
pubmed-meshheading:16291592-Proto-Oncogene Proteins c-kit,
pubmed-meshheading:16291592-Translocation, Genetic,
pubmed-meshheading:16291592-fms-Like Tyrosine Kinase 3
|
pubmed:year |
2006
|
pubmed:articleTitle |
KIT mutations, and not FLT3 internal tandem duplication, are strongly associated with a poor prognosis in pediatric acute myeloid leukemia with t(8;21): a study of the Japanese Childhood AML Cooperative Study Group.
|
pubmed:affiliation |
Department of Hematology/Oncology, Gunma Children's Medical Center, 779 Shimohakoda, Kitatachibana, Gunma 377-8577, Japan.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't,
Multicenter Study
|